Evidence map›Paper›PMID 30970556›Full record

ArticleInternational journal of molecular sciences2019

Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities⁻Neurocognitive Study (ARIC-NCS).

Danni Li, Jeffrey R Misialek, Clifford R Jack, Michelle M Mielke, David Knopman, Rebecca Gottesman, Tom Mosley, Alvaro Alonso

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Plasma Sphingomyelins in Late-Onset Alzheimer's Disease.Journal of Alzheimer's disease : JAD · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Danni LiDepartment of Lab Medicine and Pathology, University of Minnesota, 420 Delaware Street SE, MMC 609, Minneapolis, MN 55455, USA. dannili@umn.edu.ORCID 0000-0002-0608-2831
Jeffrey R MisialekDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA. misi0020@umn.edu.
Clifford R JackDepartment of Radiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. jack.clifford@mayo.edu.ORCID 0000-0001-7916-622X
Michelle M MielkeDepartment of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55906, USA. mielke.michelle@mayo.edu.ORCID 0000-0001-7177-1185
David KnopmanDepartment of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. knopman@mayo.edu.
Rebecca GottesmanDepartment of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA. rgottesm@jhmi.edu.
Tom MosleyDepartment of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA. tmosley@umc.edu.
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. alvaro.alonso@emory.edu.ORCID 0000-0002-2225-8323

Funding

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028U01HL096812 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, THOMAS H MOSLEY · 2010 to 2026
$65.7M
ARIC Neurocognitive Study (ARIC-NCS)U01HL096902 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2010 to 2018
$7.4M
Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and/or Cognitive Training in Amnestic Mild Cognitive ImpairmentR01AG059654 · NIA · UNIVERSITY OF MINNESOTA · PI LI, DANNI · 2018 to 2022
$2.2M
Identification of plasma hydroxysphingolipids as biomarkers of demyelination and neurodegeneration underlying physical function decline in older adultsR21AG059068 · NIA · UNIVERSITY OF MINNESOTA · PI LI, DANNI · 2018 to 2019
$449k
NHLBI NIH HHS U01 HL096812NHLBI NIH HHS U01 HL096902NIA NIH HHS R01 AG059654NIA NIH HHS R21 AG059068
6 · The paper itself

Abstract

backgroundPlasma metabolites are associated with cognitive and physical function in the elderly. Because cerebral small vessel disease (SVD) and neurodegeneration are common causes of cognitive and physical function decline, the primary objective of this study was to investigate the associations of six plasma metabolites (two plasma phosphatidylcholines [PCs]: PC aa C36:5 and PC aa 36:6 and four sphingomyelins [SMs]: SM C26:0, SM [OH] C22:1, SM [OH] C22:2, SM [OH] C24:1) with magnetic resonance imaging (MRI) features of cerebral SVD and neurodegeneration in older adults.

methodsThis study included 238 older adults in the Atherosclerosis Risk in Communities study at the fifth exam. Multiple linear regression was used to assess the association of each metabolite (log-transformed) in separate models with MRI measures except lacunar infarcts, for which binary logistic regression was used.

resultsHigher concentrations of plasma PC aa C36:5 had adverse associations with MRI features of cerebral SVD (odds ratio of 1.69 [95% confidence interval: 1.01, 2.83] with lacunar infarct, and beta of 0.16 log [cm3] [0.02, 0.30] with log [White Matter Hyperintensities (WMH) volume]) while higher concentrations of 3 plasma SM (OH)s were associated with higher total brain volume (beta of 12.0 cm3 [5.5, 18.6], 11.8 cm3 [5.0, 18.6], and 7.3 cm3 [1.2, 13.5] for SM [OH] C22:1, SM [OH] C22:2, and SM [OH] C24:1, respectively).

conclusionsThis study identified associations between certain plasma metabolites and brain MRI measures of SVD and neurodegeneration in older adults, particularly higher SM (OH) concentrations with higher total brain volume.

Indexed as

AgedAged, 80 and overAtherosclerosisBrainFemaleHumansLinear ModelsMagnetic Resonance ImagingMaleNeurodegenerative DiseasesPhosphatidylcholinesProspective StudiesRisk AssessmentSphingomyelinsPhosphatidylcholinesSphingomyelinsbrain atrophycerebral small vessel diseasemetabolomicsneurodegenerationplasmasphingomyelins

Identifiers

PMID30970556
PMCPMC6479561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.